The H2304E1 Study: Efficacy and Safety of Everolimus With Reduced Tacrolimus Versus Standard Tacrolimus in De Novo Liver Transplant Recipients at 36 Months.

被引：0
|
作者：
De Simone, P. [1 ]
Kaiser, G. M. [1 ]
De Carlis, L. [1 ]
Metselaar, H. J. [1 ]
Duvoux, C. [1 ]
Nevens, F. [1 ]
Fischer, L. [1 ]
Fung, J. [1 ]
Dong, G. [1 ]
Rauer, B. [1 ]
Junge, G. [1 ]
Saliba, F. [1 ]
机构：
[1] H2304E1 Study Grp, Pisa, Italy
来源：
LIVER TRANSPLANTATION | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
O-10
引用
收藏
页码：S106 / S106
页数：1
相关论文
共 50 条
  • [41] RANDOMIZED, MULTICENTER STUDY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: RESULTS AT 24 MONTHS
    Duvoux, C.
    Saliba, F.
    Durand, F.
    Neau-Cransac, N.
    Hardwigsen, J.
    Pageaux, G.
    Boleslawski, E.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 2 - 2
  • [42] Everolimus with Minimized Tacrolimus in Lung Transplant Recipients: 1 Year Efficacy and Safety
    Schoeppler, K.
    Lyu, D.
    Kim, I.
    Grazia, T.
    Crossno, J.
    Christians, U.
    Zamora, M. R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 306 - 307
  • [43] RANDOMIZED, MULTICENTER STUDY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: RESULTS AT 12 MONTHS
    Saliba, Faouzi
    Duvoux, Christophe
    Durand, Francois
    Neau-Cransac, Martine
    Hardwigsen, Jean
    Pageaux, Georges
    Boleslawski, Emmanuel
    TRANSPLANT INTERNATIONAL, 2012, 25 : 39 - 39
  • [44] The ATHENA Study: 12 Months Safety and Efficacy Data from Everolimus Combined with Tacrolimus or Cyclosporine Compared to a Standard Tacrolimus-Mycophenolate Regimen in De Novo Kidney Transplant Patients.
    Suwelack, B.
    Sommerer, C.
    Dragun, D.
    Witzke, O.
    Hugo, C.
    Kamar, N.
    Merville, P.
    Hauser, A.
    Schenker, P.
    Junge, M.
    Nashan, B.
    Thaiss, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 259 - 260
  • [45] EVEROLIMUS PLUS REDUCED TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS ACHIEVES COMPARABLE OVERALL EFFICACY WITH FEWER BIOPSY-PROVEN ACUTE REJECTIONS VERSUS STANDARD TACROLIMUS: 24-MONTH RESULTS OF A RANDOMIZED TRIAL
    Fung, J.
    Fischer, L.
    Kaiser, G.
    Jonas, S.
    Heise, M.
    Schemmer, P.
    Pascher, A.
    Schlitt, H.
    Paulus, E.
    Mertens, M.
    Nevens, F.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 4 - 4
  • [46] Efficacy and Safety of Everolimus Plus Low-Dose Tacrolimus Versus Mycophenolate Mofetil Plus Standard-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Data
    Qazi, Y.
    Shaffer, D.
    Kaplan, B.
    Kim, D. Y.
    Luan, F. L.
    Peddi, V. R.
    Shihab, F.
    Tomlanovich, S.
    Yilmaz, S.
    McCague, K.
    Patel, D.
    Mulgaonkar, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (05) : 1358 - 1369
  • [47] Efficacy and Safety of Everolimus With Reduced Tacrolimus in Living-Donor Liver Transplant Recipients: Baseline Data from the H2307 Study
    Levy, G.
    Suh, K. S.
    Joh, J. W.
    Yoshizumi, T.
    Lee, W. C.
    Genyk, Y.
    Grant, D.
    Martzloff, E. -D.
    Sips, C.
    Wang, Z.
    Lopez, P.
    TRANSPLANTATION, 2015, 99 : 150 - 150
  • [48] Everolimus-Facilitated Reduction Of Tacrolimus Provides Comparable Efficacy And Superior Renal Function Versus Standard Tacrolimus In De Novo Liver Transplant Recipients: 24-Month Results Of A Randomized Trial
    Saliba, Faouzi
    De Simone, Paolo
    Nevens, Frederik
    De Carlis, Luciano
    Metselaar, Herold
    Beckebaum, Susanne
    Jonas, Sven
    Sudan, Debra
    Fischer, Lutz
    Fung, John J.
    Dong, Gaohong
    Lopez, Patricia M.
    Junge, Guido
    HEPATOLOGY, 2012, 56 (06) : 1519 - 1519
  • [49] Wound Healing Events and Arterial Complications with Everolimus Versus Tacrolimus Based Regimens in De Novo Liver Transplant Recipients
    Fischer, L.
    De Simone, P.
    Fung, J.
    Nevens, F.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Chapman, W. C.
    Jiang, H.
    Lopez, P.
    Junge, G.
    De Carlis, L.
    LIVER TRANSPLANTATION, 2012, 18 : S87 - S87
  • [50] Efficacy and Safety of Everolimus With Low-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Randomized Study
    Qazi, Y.
    Shaffer, D.
    Kaplan, B.
    Kim, D.
    Luan, F.
    Peddi, V.
    Shihab, F.
    Tomlanovich, S.
    Yilmaz, S.
    McCague, K.
    Patel, D.
    Mulgaonkar, S.
    TRANSPLANTATION, 2014, 98 : 80 - 80
12345